TOKYO, Mar 09 (Pulse News Wire) – Perseus Proteomics Inc. (4882.T) reported significant exercise of warrants during the period from March 2 to March 9, 2026.
A total of 14,500 warrants were exercised, representing 39.40% of the outstanding 36,800 warrants issued on January 5, 2026. As of March 9, 2026, 19,299 warrants remained unexercised out of the initial issuance. Details of warrant exercises during the period included: - On March 2, 2026, 203 warrants were exercised. - On March 5, 2026, 191 warrants were exercised, resulting in the delivery of 250,000 shares.
- On March 6, 2026, 191 warrants were exercised without share delivery. - , 214 warrants were exercised, leading to the delivery of 1,200,000 shares. As of the end of February 2026, there were 33,799 unexercised warrants out of a total of 36,800 issued warrants. At the same time, the number of outstanding shares was 15,049,600, including 90 treasury shares.
For more detailed information on the issuance of these warrants, refer to the announcement published on December 17, 2025, titled “Third-Party Allocation Issuance of the 29th Series of Warrants (with Price Adjustment Clause) and Conclusion of Warrant Repurchase Agreement.”.
🟢 Confidence: High AI-translated content.